Stocks and Investing Stocks and Investing
Thu, September 29, 2022
Wed, September 28, 2022
Tue, September 27, 2022
Mon, September 26, 2022
Fri, September 23, 2022

Josh Schimmer Upgraded (SPRO) to Buy and Increased Target to $8 on, Sep 23rd, 2022


Published on 2024-10-27 23:05:22 - WOPRAI
  Print publication without navigation


Josh Schimmer of Evercore ISI Group, Upgraded "Spero Therapeutics, Inc." (SPRO) to Buy and Increased Target from $2 to $8 on, Sep 23rd, 2022.

Josh has made no other calls on SPRO in the last 4 months.



There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Josh's Rating of Hold.



This is the rating of the analyst that currently disagrees with Josh


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $7 on, Monday, August 15th, 2022